• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏替代治疗方式决定慢性肾脏病患者的内毒素血症和中性粒细胞功能障碍。

Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.

Department of Internal Medicine, Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.

出版信息

Sci Rep. 2016 Oct 4;6:34534. doi: 10.1038/srep34534.

DOI:10.1038/srep34534
PMID:27698480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5048306/
Abstract

Bacterial infection and sepsis are common complications of chronic kidney disease (CKD). A vicious cycle of increased gut permeability, endotoxemia, inadequate activation of the innate immune system and resulting innate immune dysfunction is hypothesized. We assessed endotoxemia, neutrophil function and its relation to oxidative stress, inflammation and gut permeability in patients with CKD grade 3-5 without renal replacement therapy (CKD group, n = 57), patients with CKD stage 5 undergoing haemodialysis (HD, n = 32) or peritoneal dialysis (PD, n = 28) and patients after kidney transplantation (KT, n = 67) in a cross-sectional observational study. In HD patients, endotoxin serum levels were elevated and neutrophil phagocytic capacity was decreased compared to all other groups. Patients on HD had a significantly higher mortality, due to infections during follow up, compared to PD (p = 0.022). Oxidative stress, neutrophil energy charge, systemic inflammation and gut permeability could not completely explain these differences. Our findings suggest that dialysis modality and not renal function per se determine the development of neutrophil dysfunction and endotoxemia in CKD-patients. HD patients are particularly prone to neutrophil dysfunction and endotoxemia whereas neutrophil function seems to improve after KT. Multi-target approaches are therefore warranted to improve neutrophil function and potentially reduce the rate of infections with patients undergoing haemodialysis.

摘要

细菌感染和败血症是慢性肾脏病(CKD)的常见并发症。人们假设,肠道通透性增加、内毒素血症、固有免疫系统激活不足以及由此导致的固有免疫功能障碍之间存在恶性循环。我们在一项横断面观察性研究中评估了 3-5 期未接受肾脏替代治疗的 CKD 患者(CKD 组,n=57)、接受血液透析(HD)的 CKD 5 期患者(n=32)或腹膜透析(PD)的患者(n=28)和肾移植后患者(KT,n=67)的内毒素血症、中性粒细胞功能及其与氧化应激、炎症和肠道通透性的关系。与其他所有组相比,HD 患者的血清内毒素水平升高,中性粒细胞吞噬能力下降。与 PD 相比(p=0.022),HD 患者在随访期间因感染导致的死亡率显著更高。氧化应激、中性粒细胞能量状态、全身炎症和肠道通透性不能完全解释这些差异。我们的研究结果表明,透析方式而不是肾功能本身决定了 CKD 患者中性粒细胞功能障碍和内毒素血症的发展。HD 患者尤其容易发生中性粒细胞功能障碍和内毒素血症,而中性粒细胞功能似乎在 KT 后得到改善。因此,需要采用多靶点方法来改善中性粒细胞功能,并可能降低接受血液透析患者的感染率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/88103ae3f61d/srep34534-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/3476fa903c32/srep34534-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/42c93a31a60a/srep34534-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/8e57cf30efac/srep34534-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/88103ae3f61d/srep34534-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/3476fa903c32/srep34534-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/42c93a31a60a/srep34534-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/8e57cf30efac/srep34534-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286d/5048306/88103ae3f61d/srep34534-f4.jpg

相似文献

1
Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.肾脏替代治疗方式决定慢性肾脏病患者的内毒素血症和中性粒细胞功能障碍。
Sci Rep. 2016 Oct 4;6:34534. doi: 10.1038/srep34534.
2
Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.慢性肾脏病患者容量超负荷、慢性炎症与左心室功能障碍之间的相关性。
Clin Nephrol. 2016;86 (2016)(13):131-135. doi: 10.5414/CNP86S127.
3
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.循环内毒素血症:慢性肾脏病全身炎症和心血管疾病的一个新的因素。
Clin J Am Soc Nephrol. 2011 Jan;6(1):133-41. doi: 10.2215/CJN.04610510. Epub 2010 Sep 28.
4
Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.从过渡到肾脏替代治疗看内皮功能障碍和低度炎症。
PLoS One. 2019 Sep 13;14(9):e0222547. doi: 10.1371/journal.pone.0222547. eCollection 2019.
5
Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation.血浆蛋白羰基作为慢性肾脏病、透析和移植中氧化应激的生物标志物。
Oxid Med Cell Longev. 2020 Nov 24;2020:2975256. doi: 10.1155/2020/2975256. eCollection 2020.
6
The activation of complement system in different types of renal replacement therapy.不同类型肾脏替代治疗中补体系统的激活。
J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.12. Epub 2020 Aug 8.
7
The contact system in chronic kidney disease and hemodialysis - A cross-sectional study.
Thromb Res. 2025 Jan;245:109229. doi: 10.1016/j.thromres.2024.109229. Epub 2024 Nov 19.
8
Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.血浆溶血磷脂浓度与慢性肾脏病及肾脏替代治疗类型的相关性。
Lipids Health Dis. 2019 Apr 4;18(1):85. doi: 10.1186/s12944-019-1040-5.
9
Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.慢性肾脏病、腹膜透析和血液透析患者的遗传损伤:一项对比研究。
Mutagenesis. 2013 Mar;28(2):219-25. doi: 10.1093/mutage/ges075.
10
Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions?慢性肾脏病患者的疾病认知和治疗认知:不同阶段,不同认知?
Br J Health Psychol. 2013 May;18(2):244-62. doi: 10.1111/bjhp.12002. Epub 2012 Nov 6.

引用本文的文献

1
Significance of neutrophil extracellular traps and low-density granulocytes in advanced chronic kidney disease (stage 5D) cases with COVID-19.中性粒细胞胞外诱捕网和低密度粒细胞在晚期慢性肾脏病(5D期)合并新型冠状病毒肺炎病例中的意义
Ren Fail. 2025 Dec;47(1):2559093. doi: 10.1080/0886022X.2025.2559093. Epub 2025 Sep 15.
2
Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease.生物信息学研究表明TNFAIP6是一个候选基因,并提示其在慢性肾脏病血液透析治疗中的潜在相互作用。
Ren Fail. 2025 Dec;47(1):2528757. doi: 10.1080/0886022X.2025.2528757. Epub 2025 Jul 13.
3

本文引用的文献

1
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.随机临床试验:多种益生菌与安慰剂对肝硬化患者先天免疫功能、细菌移位及肠道通透性的影响
Aliment Pharmacol Ther. 2016 Nov;44(9):926-935. doi: 10.1111/apt.13788. Epub 2016 Sep 4.
2
Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis.糖尿病患者在规律血液透析期间肝脾血管收缩增加。
PLoS One. 2015 Dec 29;10(12):e0145411. doi: 10.1371/journal.pone.0145411. eCollection 2015.
3
Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate.
Neutrophil Function in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
慢性肾脏病患者的中性粒细胞功能:系统评价与荟萃分析
Acta Physiol (Oxf). 2025 Jun;241(6):e70057. doi: 10.1111/apha.70057.
4
Oral dysbiosis initiates periodontal disease in experimental kidney disease.口腔微生物群失调引发实验性肾病中的牙周疾病。
Nephrol Dial Transplant. 2025 May 30;40(6):1187-1202. doi: 10.1093/ndt/gfae266.
5
Cytopenias in pediatric kidney transplant recipients: preceding factors and clinical consequences.儿科肾移植受者的细胞减少症:前置因素和临床后果。
Pediatr Nephrol. 2023 Oct;38(10):3445-3454. doi: 10.1007/s00467-023-05905-1. Epub 2023 Apr 20.
6
Gut-Kidney Axis Investigations in Animal Models of Chronic Kidney Disease.肠道-肾脏轴在慢性肾脏病动物模型中的研究。
Toxins (Basel). 2022 Sep 7;14(9):626. doi: 10.3390/toxins14090626.
7
Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017.2004 - 2017年低结核病流行国家实体器官移植或透析患者中的结核病
Tuberc Res Treat. 2020 Apr 25;2020:7636975. doi: 10.1155/2020/7636975. eCollection 2020.
8
Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis.疾病严重程度和质子泵抑制剂的使用对肝硬化患者的粪便微生物群组成影响最大。
Liver Int. 2020 Apr;40(4):866-877. doi: 10.1111/liv.14382. Epub 2020 Jan 24.
9
Gut Microbiota and Cardiometabolic Risk Factors in Hemodialysis Patients: A Pilot Study.血液透析患者的肠道微生物群与心血管代谢危险因素:一项初步研究。
Top Clin Nutr. 2019 Apr-Jun;34(2):153-160. doi: 10.1097/TIN.0000000000000170.
10
Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score.使用新型生物标志物算法和临床风险评分对心脏手术前后患者的急性肾损伤风险进行分层。
Sci Rep. 2019 Nov 18;9(1):16963. doi: 10.1038/s41598-019-53349-1.
通过检测血浆内毒素和二胺氧化酶评估大剂量甲氨蝶呤治疗的急性淋巴细胞白血病患儿的肠道通透性
Anticancer Agents Med Chem. 2016;16(3):387-92. doi: 10.2174/1871520615666150812125955.
4
CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.CD66b过表达和C5a受体缺失作为金黄色葡萄球菌诱导的中性粒细胞功能障碍的表面标志物
PLoS One. 2015 Jul 15;10(7):e0132703. doi: 10.1371/journal.pone.0132703. eCollection 2015.
5
Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker.评估化疗诱导的黏膜屏障功能障碍的生物标志物:寻找一种快速简便的生物标志物。
Clin Lab. 2015;61(3-4):371-8. doi: 10.7754/clin.lab.2014.140712.
6
Association of plasma diamine oxidase and intestinal fatty acid-binding protein with severity of disease in patient with heat stroke.热射病患者血浆二胺氧化酶和肠脂肪酸结合蛋白与疾病严重程度的关系
Am J Emerg Med. 2015 Jul;33(7):867-71. doi: 10.1016/j.ajem.2015.01.047. Epub 2015 Feb 2.
7
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.慢性肾脏病中肠道微生物菌群改变和肠上皮屏障结构与功能障碍:性质、机制、后果和潜在治疗。
Nephrol Dial Transplant. 2016 May;31(5):737-46. doi: 10.1093/ndt/gfv095. Epub 2015 Apr 16.
8
Why do young people with chronic kidney disease die early?为什么患有慢性肾病的年轻人会早逝?
World J Nephrol. 2014 Nov 6;3(4):143-55. doi: 10.5527/wjn.v3.i4.143.
9
Endotoxemia in end-stage kidney disease.终末期肾病中的内毒素血症
Semin Dial. 2015 Jan-Feb;28(1):59-67. doi: 10.1111/sdi.12280. Epub 2014 Jul 13.
10
Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.肠道微生物群改变在慢性肾脏病全身炎症和心血管疾病中的作用
Future Microbiol. 2014;9(3):399-410. doi: 10.2217/fmb.13.165.